Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others), and, By Region -Trends, Analysis and Forecast till 2030

The clinical trials are experiments that are conducted under clinical research and follow a regulated protocol. The clinical trials are used to evaluate the effectiveness and safety of medications or medical devices by monitoring their effects on large groups of people. The clinical research trials are conducted by government health agencies such as NIH, researchers affiliated with a hospital or university medical program, independent researchers, or private industry. These experiments are primarily performed to obtain data regarding the safety and efficacy of newly developed drugs. The clinical trial data is mandatory for drug approval, as well as for it to be introduced in the market. The clinical trials are performed under three phases (I, II, and III), which depends upon various factors. This process is not only expensive, but also time consuming, and requires expertise at all stages.Clinical Trials Market accounted for USD 42.4 billion in 2020 and is estimated to be USD 74.2 billion by 2030 and is anticipated to register a CAGR of 5.5%.

Increase in investment

The globalization leads to an increase in investment in new product development in emerging countries thus leading to the clinical trials market growth. The growing prevalence of rare and new disease cases is a factor boosting the growth of clinical target market.

Increase in patients rate for specific disease

The increase in patients rate for a specific disease, stimulates biopharmaceutical companies to invest more in clinical trials, thus leading to the growth of clinical trials market. In addition, introduction of new medications such as personalized medicine and growing demand for CROs for conducting clinical trials is expected to drive clinical trials market across the globe.  Further, lack of skilled clinical research workforce is restraining the growth of the target market.

 The regulatory quality in emerging markets and stringent regulations for patient enrollment hampers the demand of clinical trials market.

The clinical trials market is segmented by phases, by study design, by indication, and by region.

On the basis of phases, the clinical trial market is sub segmented into phase I, phase II, phase III, phase IV. On the basis of Study Design, the target market is segmented into interventional trials, observational trials, and expanded access trials. On the basis of indications, the clinical trials market is segmented into autoimmune, blood disorders, cancer, circulatory, CNS, congenital, CVS, dermatology, ear, gastrointestinal, genitourinary, infections, mental disorders, metabolic, Musculoskeletal, nose, ophthalmology and others.   

Regional Insights:                                      

For detailed understanding of market dynamics,on the basis of region, the target market is sun segmented into North America, Asia Pacific, Europe, Latin America and Middle East & Africa. North America is expected to be the leading region in the clinical trials market due to the ample of funds availability. Asia Pacific is expected to show a growth in clinical trials market attributed to the initiatives from government and contributions from academic laboratories.                                         

Detailed Segmentation:

 Clinical Trials Market, By Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Market, By Study Design:

• Interventional Trials
• Observational Trials
• Expanded Access Trials

Clinical Trials Market, By Indication:

• Autoimmune
• Blood Disorders
• Cancer
• Circulatory
• CNS
• Congenital
• CVS
• Dermatology
• Ear
• Gastrointestinal
• Genitourinary
• Infections
• Mental Disorders
• Metabolic
• Musculoskeletal
• Nose
• Ophthalmology
• Others

Clinical Trials Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key operators of clinical trials are Eli Lilly and Company, Novo Nordisk A/S, Ranbaxy Laboratories Ltd, Sanofi Aventis A.S., Roche Group, Biocair International Ltd, Catalent Pharma Solutions, PAREXEL International Corporation, Thermo Fischer Scientific, Inc

• Eli Lilly and Company
• Thermo Fischer Scientific, Inc.
• PAREXEL International Corporation
• Catalent Pharma Solutions
• Biocair International Ltd
• Roche Group
• Sanofi Aventis A.S.
• Ranbaxy Laboratories Ltd
• Novo Nordisk A/S